Amikacin and Cephalothin: Empiric Regimen for Granulocytopenic Cancer Patients

Amikacin (15 mg/kg per day) was used in combination with cephalothin (7 g/m(2) per day) as an empiric regimen for de novo febrile (>101°F [38.3°C]) episodes in 93 granulocytopenic (<1,000/mm(3)) cancer patients. Both drugs were given intravenously in four equal doses every 6 h. The response ra...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Hahn, Davis M., Schimpff, Stephen C, Young, Viola Mae, Fortner, Clarence L., Standiford, Harold C., Wiernik, Peter H.
Médium: Artigo
Jazyk:Inglês
Vydáno: 1977
Témata:
Pharmacology and Therapeutics
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC429987/
https://ncbi.nlm.nih.gov/pubmed/335967
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky